At its annual Medical Writing & Communication Conference in November 2018, the American Medical Writers Association (AMWA) convened executives of medical writing departments at top biotech and pharmaceutical companies to discuss workforce trends and advancements in medical writing.
Joan Affleck, MBA, ELS, Executive Director and Head of Medical Writing at Merck & Co, chaired AMWA’s inaugural Medical Writing Executives Forum, an annual invitational event for executives to optimize the functioning of their medical writing departments while preparing their medical writing teams for future success. These leaders shared information on how they have embraced challenges, recognized the need to evolve, and applied creativity within their organizations to develop skilled medical writers and efficient medical writing departments.
At the event, Ms. Affleck noted, “AMWA’s initiative in launching an Executive Forum for leaders of medical writing in the biopharmaceutical industry speaks to the organization’s commitment to serving its constituents, and to the urgent need to address workforce trends that have a potential to affect the clear, factual communication of scientific and medical information. The quality of our health care and medicines is a direct result of shared data, interpretation, and best practice. Medical writers are key to the communication of those messages and will benefit from a strong AMWA-industry partnership.”
Whether the audience is a regulatory agency or the public, communicating clearly about new drugs and treatments for diseases depends on skilled medical communicators. AMWA will continue to engage the leaders of medical writing departments to provide relevant educational resources and programs that support the professional development of current medical communicators, and to prepare the next generation of medical communicators to meet workplace demands.
Susan Krug, MS, CAE
Executive Director, American Medical Writers Association